Roche’s Tecentriq gets FDA Priority Review for specific stage 3 colon cancer
Over one million people are diagnosed globally each year and around 30% of stage 3 patients relapse within five years
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
GSK to acquire biopharma Nuvalent for $10.6bn
Two of Nuvalent’s NSCLC therapies have received FDA Breakthrough Therapy and Orphan Drug Designations
Lilly to acquire LimmaTech Biologics and Vaccine Company in deals totalling $2.33bn
The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease
Roche’s Tecentriq gets FDA Priority Review for specific stage 3 colon cancer
Over one million people are diagnosed globally each year and around 30% of stage 3 patients relapse within five years
EMA celebrates diversity and inclusion in science and healthcare
The EU body underlines its commitment to diverse perspectives in medicines regulation
PMEA welcome Simon Bates as new Chair of the judging panel
Roche and Alnylam share their experiences entering the PMEAs
Latest content
Oriva Therapeutics appoints Agnès Arbat as CEO
Arbat previously held senior roles in women’s health at Oxolife, Bayer and Organon
Read More
Ardena appoints Ariane de Ganck as Chief Scientific Officer
de Ganck was previously lead of the company’s Drug Product division
Read More
VML Health appoints Jason Graff as Global CCO
Graff joins VML Health from AREA 23 New York
Read More
Gates Medical Research Institute appoints Charles Wells as Chief Medical Officer and Head of Medical Development
Wells previously served in executive leadership roles at Sanofi and Evotec
Read More
Intelligence
The next frontier in clinical trials: navigating multi-disease research with GLP-1s
As GLP-1s redefine the treatment landscape for obesity, they are also promising candidates to influence a wide range of disease pathways
Read More
Headline trade and market deals are opening doors to greater patient access
Regulatory changes and tariffs have created a positive climate for investment, innovation and, critically, patient access to therapies
Read More
Men’s health: the gap between awareness and action is where men’s lives are lost
Until the gap between what healthcare systems can offer and how men actually engage with them is closed, outcomes will continue to deteriorate
Read More
The digital age and the advance of AI – pushing communications to new heights
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read More
GenAI: embracing the transformation – with caution
Despite the GenAI fervour, there is an acute need to prepare organisations to understand which specific tools they need and how to use them
Read More
The race to explore and harness GenAI in healthcare
AI has graduated from being a procurer of efficiencies to seemingly an enabler of unimagined possibilities
Read More
Blogs
Latest
New benchmark reveals significant digital maturity gap across UK POM companies’ product-information estates
June 11, 2026 | Genetic Digital|ABPI, Digital, Pharma, Website, compliance, digital estate, digital marketing, emc, pom, prescription only medicines
A new benchmark maps 100 UK prescription medicine companies across five maturity bands and finds a market at very different stages of digital development
The words around health matter
June 4, 2026 | Mednet|Language choices, Making Health Whole, healthcare communications, healthcare innovation, medcomms
The language used in healthcare can influence how people perceive their health, feel about themselves, and engage with treatments. Whole-person communication can help reduce stigma …
Medscape Education Brings AI to the Hematology Frontline at EHA 2026
June 2, 2026 | Medscape Education|AI, EHA, EHACongress26, Symposia, heamatology, hematology
Medscape Education is supporting a dedicated AI symposium at the 2026 European Hematology Association (EHA) Annual Congress in Stockholm on June 11, 2026.
What do HCPs want from pharma medical information sites in 2026?
May 29, 2026 | Graphite Digital|HCP engagement, digital experience, medical, pharma medical, web design
At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine …
The Ripple Effect: Why Connection is the Heart of Healthcare Leadership
May 28, 2026 | Medscape Education|#WomenInHealthcare #Leadership #MedEd
In the fast-paced environment of clinical medicine, it is easy to focus solely on data and outcomes. However, as Dr. Toyin Nwafor (Gilead Sciences) and …
How to build a commercialisation strategy fit for biopharma’s new evidence era
June 11, 2026 | Nmblr|
The bar for evidence has never been higher. The EU’s Joint Clinical Assessment process went live in January 2025, introducing harmonised clinical evidence requirements across …
Where translation falls short in practice
June 10, 2026 | Cuttsy + Cuttsy|Localisation, clinical trial, translation
Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.
From activity to impact: 5 takeaways from MAPS Americas 2026
June 2, 2026 | Inizio|
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed …
Where it all began – why we developed The Experience Gap
June 1, 2026 | Cuttsy + Cuttsy|Participant engagement, clinical trials, communication
Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, …
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
May 12, 2026 | Inizio|
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed …